c-myc is required for osteoclast differentiation

R. Battaglino, D. Kim, J. Fu, B. Vaage, X. Y. Fu, Phil Stashenko

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

The role of the receptor activator of nuclear factor κB (NF-κB) ligand (RANKL) - a tumor necrosis factor (TNF)-related cytokine - in osteoclast formation has been established clearly. However, the downstream signaling pathways activated by this cytokine remain largely unknown. To identify genes that play a role in osteoclastogenesis, we used RAW 264.7 mouse monocytes as a model system for the differentiation of multinucleated osteoclasts from mononucleated precursors. RAW 264.7 cells were induced with RANKL to form multinucleated giant osteoclast-like cells (OCLs) that expressed a number of osteoclast-specific markers and were able to form resorption pits on both calcium phosphate films and bone slices. This system was used to identify genes that are regulated by RANKL and may play a role in osteoclast differentiation. The proto-oncogene c-myc was strongly up-regulated in RANKL-induced OCLs but was absent in undifferentiated cells. Expression of Myc partners Max and Mad, on the other hand, was constant during OCL differentiation. We expressed a dominant negative Myc in RAW 264.7 cells and were able to block RANKL-induced OCL formation. Northern Blot analysis revealed a delay and a significant reduction in the level of messenger RNA (mRNA) for tartrate-resistant acid phosphatase (TRAP) and cathepsin K. We conclude that c-myc is a downstream target of RANKL and its expression is required for RANKL-induced osteoclastogenesis.

Original languageEnglish (US)
Pages (from-to)763-773
Number of pages11
JournalJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Volume17
Issue number5
StatePublished - 2002
Externally publishedYes

Fingerprint

Osteoclasts
Osteogenesis
Cathepsin K
Cytokines
myc Genes
Cytoplasmic and Nuclear Receptors
Northern Blotting
Genes
Monocytes
Cell Differentiation
Tumor Necrosis Factor-alpha
Ligands
Bone and Bones
Messenger RNA

Keywords

  • Bone formation
  • Myc
  • Osteoclast differentiation

ASJC Scopus subject areas

  • Surgery

Cite this

c-myc is required for osteoclast differentiation. / Battaglino, R.; Kim, D.; Fu, J.; Vaage, B.; Fu, X. Y.; Stashenko, Phil.

In: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, Vol. 17, No. 5, 2002, p. 763-773.

Research output: Contribution to journalArticle

Battaglino, R. ; Kim, D. ; Fu, J. ; Vaage, B. ; Fu, X. Y. ; Stashenko, Phil. / c-myc is required for osteoclast differentiation. In: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2002 ; Vol. 17, No. 5. pp. 763-773.
@article{a1d6ad66b04647af9097982ba9be307a,
title = "c-myc is required for osteoclast differentiation",
abstract = "The role of the receptor activator of nuclear factor κB (NF-κB) ligand (RANKL) - a tumor necrosis factor (TNF)-related cytokine - in osteoclast formation has been established clearly. However, the downstream signaling pathways activated by this cytokine remain largely unknown. To identify genes that play a role in osteoclastogenesis, we used RAW 264.7 mouse monocytes as a model system for the differentiation of multinucleated osteoclasts from mononucleated precursors. RAW 264.7 cells were induced with RANKL to form multinucleated giant osteoclast-like cells (OCLs) that expressed a number of osteoclast-specific markers and were able to form resorption pits on both calcium phosphate films and bone slices. This system was used to identify genes that are regulated by RANKL and may play a role in osteoclast differentiation. The proto-oncogene c-myc was strongly up-regulated in RANKL-induced OCLs but was absent in undifferentiated cells. Expression of Myc partners Max and Mad, on the other hand, was constant during OCL differentiation. We expressed a dominant negative Myc in RAW 264.7 cells and were able to block RANKL-induced OCL formation. Northern Blot analysis revealed a delay and a significant reduction in the level of messenger RNA (mRNA) for tartrate-resistant acid phosphatase (TRAP) and cathepsin K. We conclude that c-myc is a downstream target of RANKL and its expression is required for RANKL-induced osteoclastogenesis.",
keywords = "Bone formation, Myc, Osteoclast differentiation",
author = "R. Battaglino and D. Kim and J. Fu and B. Vaage and Fu, {X. Y.} and Phil Stashenko",
year = "2002",
language = "English (US)",
volume = "17",
pages = "763--773",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - c-myc is required for osteoclast differentiation

AU - Battaglino, R.

AU - Kim, D.

AU - Fu, J.

AU - Vaage, B.

AU - Fu, X. Y.

AU - Stashenko, Phil

PY - 2002

Y1 - 2002

N2 - The role of the receptor activator of nuclear factor κB (NF-κB) ligand (RANKL) - a tumor necrosis factor (TNF)-related cytokine - in osteoclast formation has been established clearly. However, the downstream signaling pathways activated by this cytokine remain largely unknown. To identify genes that play a role in osteoclastogenesis, we used RAW 264.7 mouse monocytes as a model system for the differentiation of multinucleated osteoclasts from mononucleated precursors. RAW 264.7 cells were induced with RANKL to form multinucleated giant osteoclast-like cells (OCLs) that expressed a number of osteoclast-specific markers and were able to form resorption pits on both calcium phosphate films and bone slices. This system was used to identify genes that are regulated by RANKL and may play a role in osteoclast differentiation. The proto-oncogene c-myc was strongly up-regulated in RANKL-induced OCLs but was absent in undifferentiated cells. Expression of Myc partners Max and Mad, on the other hand, was constant during OCL differentiation. We expressed a dominant negative Myc in RAW 264.7 cells and were able to block RANKL-induced OCL formation. Northern Blot analysis revealed a delay and a significant reduction in the level of messenger RNA (mRNA) for tartrate-resistant acid phosphatase (TRAP) and cathepsin K. We conclude that c-myc is a downstream target of RANKL and its expression is required for RANKL-induced osteoclastogenesis.

AB - The role of the receptor activator of nuclear factor κB (NF-κB) ligand (RANKL) - a tumor necrosis factor (TNF)-related cytokine - in osteoclast formation has been established clearly. However, the downstream signaling pathways activated by this cytokine remain largely unknown. To identify genes that play a role in osteoclastogenesis, we used RAW 264.7 mouse monocytes as a model system for the differentiation of multinucleated osteoclasts from mononucleated precursors. RAW 264.7 cells were induced with RANKL to form multinucleated giant osteoclast-like cells (OCLs) that expressed a number of osteoclast-specific markers and were able to form resorption pits on both calcium phosphate films and bone slices. This system was used to identify genes that are regulated by RANKL and may play a role in osteoclast differentiation. The proto-oncogene c-myc was strongly up-regulated in RANKL-induced OCLs but was absent in undifferentiated cells. Expression of Myc partners Max and Mad, on the other hand, was constant during OCL differentiation. We expressed a dominant negative Myc in RAW 264.7 cells and were able to block RANKL-induced OCL formation. Northern Blot analysis revealed a delay and a significant reduction in the level of messenger RNA (mRNA) for tartrate-resistant acid phosphatase (TRAP) and cathepsin K. We conclude that c-myc is a downstream target of RANKL and its expression is required for RANKL-induced osteoclastogenesis.

KW - Bone formation

KW - Myc

KW - Osteoclast differentiation

UR - http://www.scopus.com/inward/record.url?scp=0036233577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036233577&partnerID=8YFLogxK

M3 - Article

C2 - 12009006

AN - SCOPUS:0036233577

VL - 17

SP - 763

EP - 773

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 5

ER -